Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_assertion type Assertion NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_head.
- NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical application is practical.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_provenance.
- NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_assertion evidence source_evidence_literature NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_provenance.
- NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_assertion SIO_000772 20530282 NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_provenance.
- NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_assertion wasDerivedFrom gad-20130706 NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_provenance.
- NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_assertion wasGeneratedBy ECO_0000203 NP60207.RAaaMmLDvBRxuezE8ZU_2SGKMIfu-G-XUHW0ITP-KiRLE130_provenance.